| Literature DB >> 28988770 |
Marc Kschonsak1, Fabian Merkel1, Shveta Bisht1, Jutta Metz1, Vladimir Rybin2, Markus Hassler3, Christian H Haering4.
Abstract
Condensin protein complexes coordinate the formation of mitotic chromosomes and thereby ensure the successful segregation of replicated genomes. Insights into how condensin complexes bind to chromosomes and alter their topology are essential for understanding the molecular principles behind the large-scale chromatin rearrangements that take place during cell divisions. Here, we identify a direct DNA-binding site in the eukaryotic condensin complex, which is formed by its Ycg1Cnd3 HEAT-repeat and Brn1Cnd2 kleisin subunits. DNA co-crystal structures reveal a conserved, positively charged groove that accommodates the DNA double helix. A peptide loop of the kleisin subunit encircles the bound DNA and, like a safety belt, prevents its dissociation. Firm closure of the kleisin loop around DNA is essential for the association of condensin complexes with chromosomes and their DNA-stimulated ATPase activity. Our data suggest a sophisticated molecular basis for anchoring condensin complexes to chromosomes that enables the formation of large-sized chromatin loops.Entities:
Keywords: DNA-binding; HEAT repeat; SMC; cell division; chromosome organization; chromosome segregation; condensin; loop extrusion; mitosis; x-ray crystallography
Mesh:
Substances:
Year: 2017 PMID: 28988770 PMCID: PMC5651216 DOI: 10.1016/j.cell.2017.09.008
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582
Figure 1DNA Binding by the Ycg1–Brn1 Condensin Subcomplex
(A) Schematic representation of the five-subunit condensin complex.
(B) Ct His6-TEV-Ycs43–1222, His6-TEV-Ycg124–1006, and GST-HRV3C-Brn1336–714 proteins or equimolar combinations of the individually purified proteins were analyzed by SDS-PAGE and Coomassie staining (left panel) or used for EMSA of a 6-fluorescein-amidite (FAM)-labeled 35-bp dsDNA substrate (0.2 μM, right panel).
(C) ITC curve of the copurified Ct Ycg124–1006–His6-TEV-Brn1515–634 subcomplex binding to a 25-bp dsDNA.
See also Figure S1.
Figure S1Condensin Subunits and Protein Domains Required for DNA Binding, Related to Figure 1
(A) EMSA with 6-FAM labeled 35-bp dsDNA (0.2 μM) and copurified Ct Ycg124-1006- His6-TEV-Brn1515-634 and Ct Ycs43-1222–Ycg124-1006–His6-TEV-Brn1225-634 subcomplexes. Protein preparations used for EMSA are shown after SDS-PAGE and Coomassie staining.
(B) EMSA with Ct Ycs4, Ct Ycg1 proteins or copurified Ct Ycs4–Brn1225-512 or Ct Ycg1–Brn1515-634 subcomplexes as in (A).
(C) EMSA with copurified Ct Ycg1–His6-TEV-Brn1515-634 subcomplexes containing truncated versions of Ct Ycg1 (Ycg124-1006, Ycg178-1006, Ycg124-823, Ycg124-883, Ycg124-934, Ycg124-982) as in (A). Cartoons indicate truncations of Ycg1 secondary structure elements.
(D) EMSA with copurified Ct Ycg124-1006– His6-TEV-Brn1 subcomplexes containing truncated versions of Ct Brn1 (Brn1515-634, Brn1549-634, Brn1572-634, Brn1515-601) as in (A). Cartoons indicate truncations of Brn1 secondary structure elements.
Figure 2Structures of Ycg1–Brn1 Condensin Subcomplexes
(A) Cartoon model of Sp Cnd3–Cnd2 subcomplex based on the purified Sp Cnd31–438, 474–823–Cnd2416–544 construct. N and C termini of the HEAT-repeat subunit (yellow) and kleisin subunit (green) and the ends of a disordered region in the Cnd2 kleisin subunit (red circles) are indicated.
(B) Cartoon and surface models of the Sc Ycg1–Brn1 subcomplex based on the purified Ycg16–498, 556–932–Brn1384–529 construct. Color scheme as in (A). The Brn1 kleisin disordered linker, α4 buckle, and α1 latch regions are indicated.
(C–E) Close-up views of the Brn1 α2 (C), α4 buckle (D), and α1 latch (E) segments in the Sc Ycg1–Brn1 subcomplex.
See also Figures S2, S3, and S4 and Table S1.
Figure S2Comparison of Sp Cnd3–Cnd2 and Sc Ycg1–Brn1 Crystal Structures, Related to Figure 2
(A) Structural alignment of Sp Cnd3–Cnd2 (blue, red) and Sc Ycg1–Brn1 (yellow, green) over all Cα atoms (RMSD 2.53 Å over 715 Cα).
(B) Cartoon representation of the 19 HEAT repeats of Sc Ycg1–Brn1 (top) or of Sp Cnd3–Cnd2 (bottom). Arrows indicate positions of irregularities between canonical HEAT-repeat stretches.
(C) Positions of point mutations in Cnd3 that cause temperature or DNA damage sensitivity in Sp (Petrova et al., 2013, Xu et al., 2015) and their predicted effect based on the Cnd3–Cnd2 structure.
(D) Summary of the effects of previously identified Sc Brn1 mutations on the co-immunoprecipitation of Ycg1 from yeast cell extracts (+ no effect, – reduced Ycg1 co-immunoprecipitation, – – strongly reduced Ycg1 copurification) and on the ability of Brn1 mutant proteins to complement the deletion of the endogenous BRN1 gene (– reduced growth, – – no growth) (Piazza et al., 2014).
Figure S3Multi-sequence Alignment of Selected Condensin HEAT-Repeat and Kleisin Sequences, Related to Figures 2 and 3
(A) Sequence alignment of four yeast (Sc Saccharomyces cerevisiae, Ct Chaetomium thermophilum, Sp Schizosaccharomyces pombe, Ec Encephalitozoon cuniculi), two animal (Hs Homo sapiens, Dp Daphnia pulex), two plant (At Arabidopsis thaliana, Cm Cyanidioschyzon merolae) and two protist (Mb Monosiga brevicollis, Gt Guillardia theta) species selected from an alignment of sequences from 35 divergent species. Secondary structure elements are highlighted based on the Sc Ycg1–Brn1 structure. Sites of mutations in Sc Ycg1 that abolish DNA binding (YC1 and YC2) are highlighted by red boxes.
(B) Sequence alignments of α- (cohesin) and γ- (condensin) kleisins of four yeast and of α-, β- (condensin II), and γ- (condensin I) kleisins of two animal, two plant, and two protist (Dd Dictyostelium discoideum) species selected from an alignment of sequences from 35 divergent species as in (A). Note that yeast genomes encode no β-kleisin subunit. Secondary structure elements are highlighted based on the Sc Ycg1–Brn1 structure. DNA binding site mutations (BC1 and BC2), mutations of hydrophobic latch residues (ΦA), the phosphorylated serine residue in NCAPH (S432), and the region that was deleted in the Sc Brn1Δlinker (short loop) construct are highlighted by red boxes.
Figure S4Comparison of the Sc Ycg1–Brn1 Structure with Structures of Cohesin HEAT-Repeat Subunits, Related to Figures 2 and 3
Overview and structural alignments of Sc Ycg1–Brn1 with crystal structures of cohesin HEAT-repeat subunits Hs SA2–Scc1 (PDB: 4PK7), Ct Scc2 (PDB: 5T8V) and Lachancea thermotolerans (Lt) Pds5 (PDB: 5F0N). Alignments were generated by secondary structure matching using only C atoms from Sc Ycg1–Brn1 HEAT repeats 2 to 7 and structurally equivalent regions of the cohesin HEAT-repeat subunits.
Figure 3A Conserved Positively Charged Ycg1–Brn1 Groove Is Essential for Condensin’s Association with Chromosomes
(A) Electrostatic surface potential representation of the Sc Ycg1–Brn1 subcomplex. Regions of positively charged Brn1 (BC1, BC2) or Ycg1 (YC1, YC2) residue patches are indicated.
(B) Conservation surface representation of the Sc Ycg1–Brn1 subcomplex. Conservation scores were calculated based on an alignment of sequences from 35 evolutionary distant eukaryotic species.
(C) EMSA of a 6-FAM-labeled 35-bp dsDNA substrate (0.2 μM) with copurified Ct Ycg124–1006–His6-TEV-Brn1515–634 subcomplexes containing wild-type or charged-patch mutant versions of Ct Brn1 (BC1: Ct Brn1R539D, R541D, K542D, K544D, BC2: Bc Brn1R554D, R556D, K557D, K559D, BC1/2: Bc Brn1R539D, R541D, K542D, K544D, R554D, R556D, K557D, K559D) or Ct Ycg1 (YC1: Ct Ycg1K100D, K101D, YC2: Ct Ycg1K916D, K917D, YC1/2: Ct Ycg1K100D, K101D, K916D, K917D).
(D) ChIP-qPCR of condensin complexes containing wild-type Sc Brn1-PK6 (strain C4239) or mutant Sc Brn1BC1/2-PK6 (Sc Brn1K409D, R411D, K414D, K451D, K452D, K454D, K456D, K457D) in asynchronous cells at centromeric (CEN4) and rDNA genomic loci. Error bars indicate mean ± SD of two independent experiments with two qPCR repeats each.
(E) Tetrad dissection of BRN1/brn1Δ diploid budding yeast cells expressing no (–, strain C4237), wild-type (Brn1, strain C4239), or mutant (BC1: Sc Brn1K409D, R411D, K414D, strain C4257, BC2: Sc Brn1K451D, K452D, K454D, K456D, K457D, strain C4259, BC1/2: Sc Brn1K409D, R411D, K414D, K451D, K452D, K454D, K456D, K457D, strain C4261) versions of Brn1-PK6 from an ectopic locus under control of the endogenous promoter. Images were recorded after three days at 25°C. Genetic marker analysis identifies BRN1, brn1Δ cells (circles).
(F) Representative example images of nocodazole-arrested HeLa cells expressing mCherry-tagged histone H2B and transiently transfected Flag-EGFP-tagged NCAPH or NCAPH2 as wild-type or charged-patch mutant (BC1/2: Hs NCAPHR446D, R448D, R450D, R451D, K452D, K462D, K463D, K464D, K467D, K468D, Hs NCAPH2K329D, K332D, K333D, R335D, K350D, R351D, K352D, R353D, K354D) versions. Scale bars: 5 μm. The graph plots ratios of chromosomal to cytosolic EGFP intensities. Horizontal lines indicate median, hinges indicate first and third quartiles, and whiskers extend to the highest or lowest point from the hinges within 1.5 times interquartile range, calculated from two independent experiments with a total of n = 45 (NCAPH), n = 45 (NCAPHBC1/2), n = 31 (NCAPH2), and n = 35 (NCAPH2BC1/2) cells (p < 0.0001 by Student’s t test with Welch’s correction).
See also Figures S3, S4, and S5 and Table S2.
Figure S5The Ycg1–Brn1 Subcomplex Represents the High-Affinity DNA Binding Site in Condensin, Related to Figures 3 and 4
(A) Coomassie-stained gels of protein complexes used for EMSA (see Figure 3C).
(B) EMSA with 6-FAM-labeled 35-bp dsDNA (0.2 μM) and copurified Ct Ycs43-1222–Ycg124-1006– His6-TEV-Brn1225-634 complexes of wild-type, Brn1 mutant BC1/2 (Brn1R539D, R541D, K542D, K544D, R554D, R556D, K557D, K559D), or Ycg1 mutant YC1/2 (Ycg1K100D, K101D, K916D, K917D). Protein preparations used for EMSA are shown after SDS-PAGE and Coomassie staining.
(C) EMSA with 6-FAM-labeled 35-bp dsDNA (0.2 μM) and wild-type or Brn1 BC1/2 (Brn1K409D, R411D, K414D, K451D, K452D, K454D, K456D, K457D) mutant Sc condensin holocomplexes (Smc2–Smc4-StrepII3–Ycs4–Ycg1–Brn1-His12-HA3) or a tetrameric complex that lacks Ycg1 (Smc2–Smc4-StrepII3–Ycs4–Brn1-His12-HA3). Protein preparations used for EMSA are shown after SDS-PAGE and Coomassie staining.
(D) Immunoprecipitation of endogenous condensin complexes of strains C4237, C4239 and C4261 used for ChIP-qPCR (see Figure 3D) analyzed by SDS-PAGE and Coomassie staining or western blotting against Ycg1 or the PK6 tag on Brn1.
(E) Brn1 expression levels of yeast strains C4237, C4239, C4257, C4259 and C4261 (see Figure 3E) analyzed by western blotting of whole cell lysates against the PK6 tag on Brn1 and α-tubulin as loading control.
(F) Overview of the Sc Ycg1–Brn1 crystal structure in complex with an 18-bp dsDNA (crystal form I). Experimental maps for DNA (dark gray, 1.0 σ) and a symmetry-related 18-bp dsDNA molecule (light gray) are shown.
(G) Structural alignment of Sc Ycg1–Brn1–DNA (crystal form II) and Sc Ycg1–Brn1short loop–DNA using all Cα atoms (RMSD 0.39 Å over 801 Cα). Free ends of the disordered Brn1 linker are indicated (red circles).
Figure 4Crystal Structure of Ycg1–Brn1 in Complex with DNA
(A) Cartoon and surface models of the Sc Ycg1–Brn1 complex bound to an 18-bp dsDNA substrate and to the 18-bp dsDNA of its symmetry-related neighbor, based on the Sc Ycg16–498, 556–932–Brn1384–529 construct. The ends of the disordered region of Sc Brn1 (red circles), the Brn1 kleisin disordered linker, α4 buckle, and α1 latch regions are indicated.
(B) Close-up views of the Sc Ycg1–Brn1 interaction with DNA.
(C) Schematic illustrations of the main contacts of Sc Ycg1 and Brn1 residues with the 18-bp DNAs in crystal forms I and II. Highly conserved residues are shown in bold, distant residues are shown in opaque. The length of the lines is proportional to the observed distances of H-bonds (solid lines) or ionic interactions (dotted lines).
(D) Structural alignment of Sc Ycg1–Brn1 and Sc Ycg1–Brn1–DNA (crystal form I) using all Cα atoms (RMSD 1.95 Å over 820 Cα). Arrows indicate conformational differences in the N-terminal shoulder region of Ycg1. Close-up views highlight changes of side chains in the Brn1 latch region.
(E) Structural alignment of Sc Ycg1–Brn1–DNA crystal forms I and II DNA using all Cα atoms (RMSD 0.79 Å over 685 Cα). Arrows indicate conformational differences in the DNA and in the C-terminal shoulder region of Ycg1.
See also Figure S5.
Figure 5DNA Entrapment by the Kleisin Loop
(A) Outline of the experimental setup to test whether the Brn1 loop encircles DNA.
(B) Copurified Ct Ycg124–1006–His6-TEV-Brn1515–634 subcomplexes without or with an additional cysteine pair engineered into the Brn1 latch and buckle regions (Ct Brn1E514C, R629C) were incubated with 2.1-kb circular or linear DNA substrates; DMSO solvent; or bBBr, BMOE, or DTME crosslinkers and denatured at 65°C in the presence of 1% SDS. Changes in DNA mobility were tested by EMSA and EtBr.
(C) EMSA of a 2.1-kb circular DNA using copurified Ct Ycg124–1006–His6-TEV-Brn1515–634 subcomplexes containing the Brn1E514C, R629C cysteine pair and a target site for HRV-3C protease engineered following residue P549 in the Ct Brn1 linker region (cleavable) or no-protease site (non-cleavable) as described in (B). Following addition of DNA and incubation with DMSO solvent or BMOE crosslinker, samples were treated with HRV-3C protease (±3C) or buffer only.
See also Figure S6.
Figure S6DNA Entrapment by the Kleisin Loop, Related to Figure 5
(A) Residue pairs in Sc Brn1 (green) latch and buckle segments in positions that should be crosslinkable (left panel, S384-S524, M391-T506, D395-S505) or in positions that should not be crosslinkable (right panel, S384-R508, N397-S524, K465-S524) when mutated to cysteine. Corresponding sequence homology pairs in Ct Brn1 (left panel, E514-R629, L521-S611, D525-S610; right panel, E514-Q613, A527-R629, S568-R629).
(B) Analysis of copurified Ct Ycg124-1006– His6-TEV-Brn1515-634 subcomplexes that either contain no additional cysteine residues (no cys) or additional cysteine pairs engineered into Ct Brn1 as in (listed in (A)) and a target sites for the 3C protease following Brn1 residue P549 (cleavable). Protein complexes were incubated with a 22-bp dsDNA before addition of DMSO solvent or bBBr crosslinker, followed by incubation with 3C protease (+3C) or buffer only (–3C), SDS-PAGE and Coomassie staining of two separate gels in parallel (left panel). EMSA of a 2.1-kb circular DNA with the same Ct Ycg124-1006– His6-TEV-Brn1515-634 complexes detected by EtBr staining after incubation with DMSO or bBBr crosslinker and protein denaturation (right panel).
(C) Analysis of copurified Ct Ycg124-1006– His6-TEV-Brn1515-634 complexes without (no cys) or with an additional cysteine pair (Brn1E514C, R629C) engineered into the latch and buckle segments of Brn1 with (cleavable) or without a 3C protease site following Brn1 residue P549 as in (B), using bBBr, BMOE or DTME crosslinkers, followed by incubation with 3C protease (+3C), dithiothreitol (+DTT) or buffer only (see Figures 5B and 5C).
(D) Analysis of copurified Ct Ycs43-1222–Ycg124-1006– His6-TEV-Brn1225-634 complexes without (no cys) or with an additional cysteine pair (Brn1E514C, R629C) engineered into the latch and buckle segments of Brn1 with (cleavable) or without a 3C protease site following Brn1 residue P549 as in (B), using BMOE crosslinker followed by incubation with 3C protease (+3C) or buffer only.
Figure S7DNA Entrapment by the Brn1 Loop is Required for High-Affinity DNA Interaction, Related to Figure 6
(A) Analysis of copurified Ct Ycs43-1222–Ycg124-1006–His6-TEV-Brn1225-634 complexes without (no cys) or with an additional cysteine pair (Brn1E514C, R629C) engineered into the latch and buckle segments of Brn1 with a 3C protease site following Brn1 residue P549. Complexes were incubated with BMOE crosslinker before analysis by SDS-PAGE and Coomassie staining (left panel) or addition of a 2.1-kb circular DNA (10 nM), followed by EMSA and EtBr staining. Note the differences in the fraction of non-shifted DNA for each protein concentration.
(B) Ct Ycg124-1006– His6-TEV-Brn1 complexes used for EMSA in analyzed by SDS-PAGE and Coomassie staining (see Figures 6B and 6C).
(C) EMSA analysis of the binding of the copurified Ct Ycs43-1222–Ycg124-1006–His6-TEV-Brn1225-634 complex to a 2.1-kb circular DNA (10 nM) or the same DNA linearized by restriction cleavage with XmnI (10 nM).
(D) Analysis of copurified Ct Ycs43-1222–Ycg124-1006–His6-TEV-Brn1225-634 complexes as wild-type or Brn1ΦD latch mutant versions (Brn1L521D, F524D, W532D, W538D) by SDS-PAGE and Coomassie staining (left panel). Protein complexes were used for EMSA with a 2.1-kb circular DNA (10 nM) substrate (right panel).
(E) Analysis of Sc condensin holocomplexes (Smc2–Smc4-StrepII3–Ycs4–Ycg1–Brn1-His12-HA3) as wild-type, Brn1ΦD latch mutant (Brn1L521D, F524D, W532D, W538D) or Brn1BC1/2 charge mutant (Brn1K409D, R411D, K414D, K451D, K452D, K454D, K456D, K457D) versions by SDS-PAGE and Coomassie staining (left panel). Protein complexes were used for EMSA with a 2.1-kb circular DNA (10 nM) substrate (right panel).
(F) Brn1 expression levels of yeast strains C4237, C4239 and C4895 (see Figure 7C) analyzed by western blotting of whole cell lysates against the PK6 tag on Brn1 and α-tubulin as loading control.
Figure 6Kleisin Loop Closure Is Required for Condensin’s Loading onto Chromosomes and DNA-Dependent Stimulation of its ATPase
(A) Close-up view of the Sc Brn1 latch-buckle interaction. Conserved Brn1 residues are marked in purple, relevant H-bonds are indicated (dotted lines). Sequence alignment of the Ycg1-interacting region of Sc, Ct, and Hs γ-kleisins. Secondary structure elements are highlighted based on the Sc Ycg1–Brn1 structure. Conserved latch and buckle regions, DNA binding site mutations (BC1 and BC2), mutations of hydrophobic latch residues (Φ), and the phosphorylated serine residue in Hs NCAPHS432 are highlighted.
(B) EMSA of a 35-bp 6-FAM-labeled linear DNA (0.2 μM) with copurified wild-type (Ct Ycg124-1006–His6-TEV-Brn1515–634), Brn1ΔN truncated (Ct Ycg124–1006–His6-TEV-Brn1539–634), and Brn1ΦD latch mutant (Ct Ycg124–1006–His6-TEV-Brn1515–634, L521D, F524D, W532D, W538D) subcomplexes detected by EtBr staining.
(C) EMSA of a 2.1-kb circular DNA (10 nM) with the same proteins as described in (B) detected by EtBr staining. Note the differences in the fraction of non-shifted DNA.
(D) Tetrad dissection of BRN1/brn1Δ diploid budding yeast cells (strains C4237, C4239, C4895) expressing ectopic copies of Brn1 wild-type or Brn1ΦD (Brn1M391D, F394D, W402D, W408D) mutant versions of versions of Brn1-PK6. Images were recorded after three days at 25°C. Genetic marker analysis identifies BRN1, brn1Δ cells (circles).
(E) Representative example images of nocodazole-arrested HeLa cells expressing mCherry-tagged histone H2B and transiently transfected EGFP-tagged NCAPH as wild-type, latch mutant (ΦA: Hs NCAPHY428A, F431A, W439A, W445A, ΦD: NCAPHY428D, F431D, W439D, W445D), or non-phosphorylatable latch (Hs NCAPHS432A) versions. Scale bars: 5 μm. The graph plots ratios of chromosomal to cytosolic EGFP intensities. Horizontal lines indicate median, hinges indicate first and third quartiles, and whiskers extend to the highest or lowest point from the hinges within 1.5 times inter-quartile range, calculated from two independent experiments with a total of n = 37 (NCAPH), n = 37 (NCAPHΦA), n = 31 (NCAPHΦD), and n = 31 (NCAPHS432A) cells (p < 0.0001 by Student’s t test with Welch’s correction).
(F) ATP hydrolysis by copurified Sc condensin holocomplexes (0.5 μM, Smc2–Smc4-StrepII3–Ycs4–Ycg1–Brn1-His12-HA3) containing wild-type, Brn1BC1/2 DNA binding (Sc Brn1K409D, R411D, K414D, K451D, K452D, K454D, K456D, K457D), Brn1ΦD latch (Sc Brn1M391D, F394D, W402D, W408D), or ATPase deficient (Sc Smc2Q147L–Smc4Q302L) mutant versions with and without a 6.4-kb relaxed circular DNA at saturated ATP concentrations (5 mM). The plot shows mean ± SD from three independent experiments.
See also Figure S7 and Table S2.
Figure 7A Safety-Belt Mechanism Anchors Condensin to Chromosomes
Model for a safety-belt mechanism of DNA binding by condensin complexes and condensin-mediated loop formation.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Mouse monoclonal anti V5-tag (anti PK6-tag) | AbD Serotec (MCA1360) | RRID: |
| Mouse monoclonal anti tubulin (TAT1) | N/A | |
| Rabbit polyclonal anti | N/A | |
| Merck | Cat#70954 | |
| Crosslinker dibromobimane (bBBr) | Sigma-Aldrich | Cat#34025 |
| Crosslinker bismaleimidoethane (BMOE) | Thermo-Fisher | Cat#22323 |
| Crosslinker disthiobismaleimidoethane (DTME) | Thermo-Fisher | Cat#22335 |
| modified purification protocol from | N/A | |
| modified purification protocol from | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| N/A | ||
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| N/A | ||
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | PDB: | |
| This work | PDB: | |
| This work | PDB: | |
| This work | PDB: | |
| This work | PDB: | |
| HeLa Kyoto H2B-mCherry | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| This work | N/A | |
| N/A | ||
| This work | N/A | |
| This work | N/A | |
| N/A | ||
| This work | N/A | |
| This work | N/A | |
| EMSA 35-mer template forward strand | This work/modified from | N/A |
| EMSA 35-mer template reverse strand | This work/modified from | N/A |
| ITC 25-mer annealed forward strand | This work/modified from | N/A |
| ITC 25-mer annealed reverse strand | This work/modified from | N/A |
| Crystallization 18-mer annealed palindromic dsDNA | This work | N/A |
| 22-mer annealed palindromic dsDNA | N/A | |
| qPCR CEN4 (SC-77) forward primer | N/A | |
| qPCR CEN4 (SC-78) reverse primer | N/A | |
| qPCR rDNA (SC-41) forward primer | N/A | |
| qPCR CEN4 (SC-42) reverse primer | N/A | |
| Plasmid pGEX6PI-Brn1336-714 (N-terminal GST-tag-HRV3C-cleavage-site, residues 336-714 of | This work | N/A |
| Plasmid pETMCN-Ycs4 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 3-1222 of | This work | N/A |
| Plasmid pETMCN-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 24-1006 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, BC1 -Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues R539D, R541D, K542D, K544D of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, BC2 -Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues R554D, R556D, K557D, K559D of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, BC1/2 -Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues R539D, R541D, K542D, K544D, R554D, R556D, K557D, K559D of | This work | N/A |
| Plasmid pETMCN-Brn1515-634 -Ycg1YC1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634 -Ycg1YC2 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634 -Ycg1YC1+YC2 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1225-512-Ycs4 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-512 of | This work | N/A |
| Plasmid pETMCN-Brn1539-634-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 539-634 of | This work | N/A |
| Plasmid pETMCN-Brn1549-634-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 549-634 of | This work | N/A |
| Plasmid pETMCN-Brn1572-634-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 572-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-601-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-601 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg178-1006 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg124-823 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg124-883 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg124-934 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634-Ycg124-982 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, E514C-R629C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues E514C, R629C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, L521C-S611C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues L521C, S611C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, D525C-S610C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues D525C, S610C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, E514C-Q613C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues E514C, Q613C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, A527C-R629C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues A527C, R629C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, S568C-R629C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues S568C, R629C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, E514C-R629C-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues E514C, R629C of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1225-634-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 of | This work | N/A |
| Plasmid pETMCN-Brn1225-634-Ycg1YC1+YC2 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 of | This work | N/A |
| Plasmid pETMCN-Brn1225-634, BC1/2-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 with mutated residues R539D, R541D, K542D, K544D, R554D, R556D, K557D, K559D of | This work | N/A |
| Plasmid pETMCN-Brn1225-634, E514C-R629C-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 with mutated residues E514C, R629C of | This work | N/A |
| Plasmid pETMCN-Brn1225-634, E514C-R629C cleavable-Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 with mutated residues E514C, R629C and HRV3C cleavage site inserted after P549 of | This work | N/A |
| Plasmid pETMCN-Brn1225-634, ΦD -Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 225-634 with mutated residues L521D, F524D, W532D, W538D of | This work | N/A |
| Plasmid pETMCN-Brn1515-634, ΦD -Ycg1 (N-terminal 6 × HIS-tag-TEV-cleavage-site, residues 515-634 with mutated residues L521D, F524D, W532D, W538D of | This work | N/A |
| Plasmid 2micron pGAL7 SMC4-StrepII3 (C-terminal 3 × StrepII-tag of | N/A | |
| Plasmid 2micron pGAL7 SMC4-StrepII3 (C-terminal 3 × StrepII-tag with mutated residue Q302L of | N/A | |
| Plasmid 2micron pGAL1 YCG1 ( | N/A | |
| Plasmid 2micron pGAL7 SMC4-StrepII3 (C-terminal 3 × StrepII-tag of | This work | N/A |
| Plasmid 2micron pGAL7 SMC4-StrepII3 (C-terminal 3 × StrepII-tag of | This work | N/A |
| Plasmid 2micron pGAL10 YCS4 ( | This work | N/A |
| Plasmid pETMCN-Brn1384-529-Ycg16-932, Δ499-555 (N-terminal 6 × HIS-tag-HRV3C-cleavage-site, residues 384-529 of | This work | N/A |
| Plasmid pETMCN-Brn1384-529, short kleisin loop-Ycg16-932, Δ499-555 (N-terminal 6 × HIS-tag-HRV3C-cleavage-site, residues 384-529 with deleted residues 418-444 of | This work | N/A |
| Plasmid pETMCN-Cnd2416-544-Cnd31-823, Δ439-473 (N-terminal 6 × HIS-tag-HRV3C-cleavage-site, residues 416-544 of | This work | N/A |
| Plasmid pC1-NCAPH (N-terminal Flag-EGFP-tag of | N/A | |
| Plasmid pC1-NCAPH2 (N-terminal Flag-EGFP-tag of | N/A | |
| Plasmid pC1-NCAPHBC1/2 (N-terminal Flag-EGFP-tag with mutations R446D, R448D, R450D, R451D, K452D, K462D, K463D, K464D, K467D, K468D of | This work | N/A |
| Plasmid pC1-NCAPH | This work | N/A |
| Plasmid pC1-NCAPH ΦD (N-terminal Flag-EGFP-tag with mutations Y428D, F431D, W439D, W445D of | This work | N/A |
| Plasmid pC1-NCAPH S432A (N-terminal Flag-EGFP-tag with mutations S432A of | This work | N/A |
| Plasmid pC1-NCAPH2BC1/2 (N-terminal Flag-EGFP-tag with mutations K329D, K332D, K333D, R335D, K350D, R351D, K352D, R353D, K354D of | This work | N/A |
| X-ray Detector Software (XDS) | ||
| SHELX | ||
| Phenix suite | ||
| CCP4 suite | ||
| COOT v0.8.2 | ||
| PyMOL | Schrödinger, LLC | |
| ConSurf | ||
| APBS | ||
| PISA | ||